Israel Englander’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,000
Closed -$576K 5822
2024
Q1
$576K Buy
+50,000
New +$425K ﹤0.01% 4726
2022
Q3
Sell
-30,400
Closed -$548K 7021
2022
Q2
$548K Buy
+30,400
New +$494K ﹤0.01% 4875

Other funds holding AHCO

Israel Englander's AHCO Position: Q2 2026 in Review

Israel Englander reduced its AdaptHealth (AHCO) stake by 47% in Q2 2026, selling an estimated $3.5M and leaving 347,920 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3308.

Israel Englander first reported a position in AHCO in Q4 2019 and has held it in 25 quarters since. The position peaked at $36.1M in Q3 2024. 237 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Israel Englander held 347,920 shares of AdaptHealth worth $3.63M as of Q2 2026.
  • Israel Englander sold 313,300 AdaptHealth shares in Q2 2026, an estimated $3.5M.
  • AdaptHealth made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3308 holding.
  • Israel Englander first reported a position in AdaptHealth in Q4 2019 and has held it in 25 quarters since.
  • Israel Englander's AdaptHealth position peaked at $36.1M in Q3 2024.
  • 237 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.